Abstract
Some photoreceptor proteins normally specific for the eye retina are aberrantly expressed in malignant tumors. These proteins include recoverin, visual rhodopsin, transducin, cGMP-phosphodiesterase 6 (PDE 6), cGMP-dependent cationic channels, guanylyl cyclase 1, rhodopsin kinase, and arrestin. By analogy with cancer-testis antigens, these photoreceptor proteins form the group of cancer-retina antigens. It is shown that an aberrant demethylation of the promoter region of recoverin is involved in the aberrant expression of this protein. The cascade Wnt5a → Frizzled-2 → transducin → PDE 6 is shown to function in skin melanoma cells, and this suggests that these cancer-retina antigens can play a functional role. The events accompanying the signal transduction in this cascade, including those involving calcium ions and cGMP-dependent protein kinase (protein kinase G), are discussed.
Similar content being viewed by others
Abbreviations
- ADC:
-
5-aza-2′-deoxycytidine
- CAR:
-
cancer-associated retinopathy
- MAR:
-
melanoma-associated retinopathy
- NSCLC:
-
non-small cell lung carcinoma
- PDE 6:
-
cGMP-phosphodiesterase 6
- SCLC:
-
small cell lung carcinoma
References
Are, C., Rajaram, S., Are, M., Raj, H., Anderson, B. O., Chaluvarya Swamy, R., Vijayakumar, M., Song, T., Pandey, M., Edney, J. A., and Cazap, E. L. (2013) A review of global cancer burden: trends, challenges, strategies, and a role for surgeons, J. Surg. Oncol., 107, 221–226.
Kulkarni, P., Shiraishi, T., Rajagopalan, K., Kim, R., Mooney, S. M., and Getzenberg, R. H. (2012) Cancer/testis antigens and urological malignancies, Nat. Rev. Urol., 9, 386–396.
Ries, L. A. G., Horner, M.-J., and Young, J. L. (2007) Introduction, in SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988–2001, Patient and Tumor Characteristics (Ries, L. A. G., Young, J. L., Keel, G. E., Eisner, M. P., Lin, Y. D., and Horner, M.- J., eds.) National Cancer Institute, SEER Program, NIH, Bethesda, pp. 1–6.
Graziano, D. F., and Finn, O. J. (2005) Tumor antigens and tumor antigen discovery, Cancer Treat. Res., 123, 89–111.
Aly, H. A. (2012) Cancer therapy and vaccination, J. Immunol. Methods, 382, 1–23.
National Cancer Institute, Fact Sheet (2011) Tumor-markers; http://www.cancer.gov/cancertopics/factsheet/detection/tumor-markers.
Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma, Science, 254, 1643–1647.
Old, L. J. (2001) Cancer/testis (CT) antigens — a new link between gametogenesis and cancer, Cancer Immun., 1, 1.
De Smet, C., and Loriot, A. (2013) DNA hypomethylation and activation of germline-specific genes in cancer, Adv. Exp. Med. Biol., 754, 149–166.
Philippov, P. P., Senin, I. I., and Koch, K.-W. (2006) Recoverin: a calcium-dependent regulator of the visual transduction, in Neuronal Calcium Sensor Proteins (Philippov, P., and Koch, K.-W., eds.) Nova Science Publishers, N. Y., pp. 139–151.
Bazhin, A. V., Schadendorf, D., Philippov, P. P., and Eichmuller, S. B. (2007) Recoverin as a cancer-retina antigen, Cancer Immunol. Immunother., 56, 110–116.
Bazhin, A. V., Schadendorf, D., Willner, N., De Smet, Ch., Henzelmann, A., Tikhomirova, N. K., Umansky, V., Philippov, P. P., and Eichmuller, S. B. (2007) Photoreceptor proteins as cancer-retina antigens, Int. J. Cancer, 120, 1268–1276.
Dizhur, A. M., Nekrasova, E. R., and Filippov, P. P. (1991) New 26-kDa protein specific for photoreceptor cells, capable of binding with immobilized delipidated rhodopsin, Biokhimiya, 56, 225–229.
Dizhoor, A. M., Ray, S., Kumar S., Niemi, G., Spencer, M., Broley, D., Walsh, K. A., Philipov, P. P., Hurley, J. B., and Stryer, L. (1991) Recoverin: a calcium sensitive activator of retinal rod guanylate cyclase, Science, 251, 915–918.
Polans, A. S., Buczylko, J., Crabb, J., and Palczewski, K. (1991) A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy, J. Cell Biol., 112, 981–989.
Adamus, G. (2009) Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy, Autoimmun. Rev., 8, 410–414.
Adamus, G. (2003) Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy, Autoimmun. Rev., 2, 63–68.
Robson, J. G., and Frishman, L. J. (2013) The rod-driven α-wave of the dark-adapted mammalian electroretinogram, Prog. Retin. Eye Res., 39, 1–22.
Jacobson, D. M., Thirkill, C. E., and Tipping, S. J. (1990) A clinical triad to diagnose paraneoplastic retinopathy, Ann. Neurol., 28, 162–167.
Chan, J. W. (2003) Paraneoplastic retinopathies and optic neuropathies, Surv. Ophthalmol., 48, 12–38.
Grunwald, G. B., Kornguth, S. E., Towfighi, J., Sassani, J., Simmonds, M. A., Housman, C. M., and Papadopoulos, N. (1987) Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Retinal immune deposits and ablation of retinal ganglion cells, Cancer, 60, 780–786.
Kornguth, S. E., Klein, R., Appen, R., and Choate, J. (1982) Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung, Cancer, 50, 1289–1293.
Kornguth, S. E., Kalinke, T., Grunwald, G. B., Schutta, H., and Dahl, D. (1986) Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome, Cancer Res., 46, 2588–2595.
Thirkill, C. E., Roth, A. M., and Keltner, J. L. (1987) Cancer-associated retinopathy, Arch. Ophthalmol., 105, 372–375.
Polans, A. S., Witkowska, D., Haley, T. L., Amundson, D., Baizer, L., and Adamus, G. (1995) Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy, Proc. Natl. Acad. Sci. USA, 92, 9176–9180.
Adamus, G., Amundson, D., and MacKay, P. G. (1998) Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy, Arch. Ophthalmol., 116, 251–253.
Klingele, T. G., Burde, R. M., Rappazzo, J. A., Isserman, M. J., Burgess, D., and Kantor, O. (1984) Paraneoplastic retinopathy, J. Clin. Neuroophthalmol., 4, 239–245.
Eltabbakh, G. H., and Hoogereland, D. L. (1995) Paraneoplastic retinopathy associated with uterine sarcoma, Gynecol. Oncol., 58, 120–123.
Matsubara, S., Yamaji, Y., Fujita, T., Kanayama, T., Yamadori, I., Sato, M., Fujita, J., Shiotani, T., and Takahara, J. (1996) Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity, Lung Cancer, 14, 265–271.
Thirkill, C. E., Keltner, J. L., Tyler, N. K., and Roth, A. M. (1993) Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy, Arch. Ophthalmol., 111, 931–937.
Salgia, R., Hedges, T. R., Rizk, M., Reimerm, R. H., and Skarin, A. T. (1998) Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma, Lung Cancer, 22, 149–152.
Bazhin, A. V., Savchenko, M. S., Shifrina, O. N., Demoura, S. A., Chikina, S. Yu., Jaques, G., Kogan, E. A., Chuchalin, A. G., and Philippov, P. P. (2004) Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors, Lung Cancer, 44, 193–198.
Maeda, A., Ohguro, H., Maeda, T., Wada, I., Sato, N., Kuroki, Y., and Nakagawa, T. (2000) Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines, Cancer Res., 60, 1914–1920.
Farber, D. B., Danciger, J. S., and Organisciak, D. T. (1991) Levels of mRNA encoding proteins of the cGMP cascade as a function of light environment, Exp. Eye Res., 53, 781–786.
McGinnis, J. F., Whelan, J. P., and Donoso, L. A. (1992) Transient, cyclic changes in mouse visual cell gene products during the light-dark cycle, J. Neurosci. Res., 31, 584–590.
Wiechmann, A. F., and Sinacola, M. K. (1997) Diurnal expression of recoverin in the rat retina, Brain Res. Mol. Brain Res., 45, 321–324.
Bazhin, A. V., Schadendorf, D., Owen, R. W., Zernii, E. Yu., Philippov, P. P., and Eichmuller, S. B. (2008) Visible light modulates the expression of cancer-retina antigens, Mol. Cancer Res., 6, 110–118.
Milam, A. H., Saari, J. C., Jacobson, S. G., Lubinski, W. P., Feun, L. G., and Alexander, K. R. (1993) Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy, Invest. Ophthalmol. Vis. Sci., 34, 91–100.
Potter, M. J., Thirkill, C. E., Dam, O. M., Lee, A. S., and Milam, A. H. (1999) Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy, Ophthalmology, 106, 2121–2125.
Bazhin, A., Dalke, C., Willner, N., Abschutz, O., Wildberger, H., Philippov, P., Dummer, R., Graw, J., Hrabe de Angelis, M., Schadendorf, D., Umansky, V., and Eichmbller, S. (2009) Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy, Int. J. Cancer, 124, 140–149.
Potter, M. J., Adamus, G., Szabo, S. M., Lee, R., Mohaseb, K., and Behn, D. (2002) Autoantibodies to transducin in a patient with melanoma-associated retinopathy, Am. J. Ophthalmol., 134, 128–130.
Pfohler, C., Preuss, K. D., Tilgen, W., Stark, A., Regitz, E., Fadle, N., and Pfreundschuh, M. (2007) Mitofilin and titin as target antigens in melanoma-associated retinopathy, Int. J. Cancer, 120, 788–795.
Matsuo, S., Ohguro, H., Ohguro, I., and Nakazawa, M. (2010) Clinicopathological roles of aberrantly expressed recoverin in malignant tumor cells, Ophthalmic Res., 43, 139–144.
Esteller, M. (2007) Epigenetic gene silencing in cancer: the DNA hypermethylome, Hum. Mol. Genet., 16, R50–R59.
Jones, P. A., and Baylin, S. B. (2007) The epigenomics of cancer, Cell, 128, 683–692.
Gronbeek, K., Hother, C., and Jones, P. A. (2007) Epigenetic changes in cancer, APMIS, 115, 1039–1059.
Li, Y., Liu, Z. L., Zhang, K. L., Chen, X. Y., Kong, Q. Y., Wu, M. L., Sun, Y., Liu, J., and Li, H. (2009) Methylation-associated silencing of S100A4 expression in human epidermal cancers, Exp. Dermatol., 18, 842–848.
De Smet, C., De Backer, O., Faraoni, F., Lurquin, C., Brasseur, F., and Boon, T. (1996) The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation, Proc. Natl. Acad. Sci. USA, 93, 7149–7153.
De Smet, C., Lurquin, C., Lethe, B., Martelange, V., and Boon, T. (1999) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter, Mol. Cell. Biol., 19, 7327–7335.
Bazhin, A. V., De Smet, Ch., Golovastova, M. O., Schmidt, J., and Philippov, P. P. (2010) Aberrant demethylation of the recoverin gene is involved in the aberrant expression of recoverin in cancer cells, Exp. Dermatol., 19, 1023–1025.
McGinnis, J. F., Austin, B., Klisak, I., Heinzmann, C., Kojis, T., Sparkes, R. S., Bateman, J. B., and Lerious, V. (1995) Chromosomal assignment of the human gene for the cancer-associated retinopathy protein (recoverin) to chromosome 17p13.1, J. Neurosci. Res., 40, 165–168.
Murakami, A., Yajima, T., and Inana, G. (1992) Isolation of human retinal genes: recoverin cDNA and gene, Biochem. Biophys. Res. Commun., 187, 234–244.
Miyagawa, Y., Ohguro, H., Odagiri, H., Maruyama, I., Maeda, T., Maeda, A., Sasaki, M., and Nakazawa, M. (2003) Aberrantly expressed recoverin is functionally associated with G-protein-coupled receptor kinases in cancer cell lines, Biochem. Biophys. Res. Commun., 300, 669–673.
Bazhin, A. V., Tambora, V., Dikova, D., Philippov, P. P., Schadendorf, D., and Eichmuller, S. B. (2010) cGMP-phosphodiesterase 6, transducin and Wnt5a/Frizzled-2-signaling control cGMP and Ca2+ homeostasis in melanoma cells, Cell. Mol. Life Sci., 67, 817–828.
Wang, H. Y., and Malbon, C. C. (2004) Wnt-Frizzled signaling to G-protein-coupled effectors, Cell. Mol. Life Sci., 61, 69–75.
Bhanot, P., Brink, M., Samos, C. H., Hsieh, J. C., Wang, Y., Macke, J. P., Andrew, D., Nathans, J., and Nusse, R. (1996) A new member of the frizzled family from Drosophila functions as a Wingless receptor, Nature, 382, 225–230.
Miller, J. R. (2002) The Wnts, Genome Biol., 3, 1–15.
Francis, S. H., Busch, J. L., and Corbin, J. D. (2010) cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action, Pharmacol. Rev., 62, 525–563.
Karakhanova, S., Golovastova, M., Philippov, P. P., Werner, J., and Bazhin, A. V. (2014) Interlude of cGMP and cGMP/protein kinase G type I in pancreatic adenocarcinoma cells, Pancreas, 43, 784–794.
Fraser, M., Chan, S. L., Chan, S. S., Fiscus, R. R., and Tsang, B. K. (2006) Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells, Oncogene, 25, 2203–2212.
Leung, E. L., Wong, J. C., Johlfs, M. G., Tsang, B. K., and Fiscus, R. R. (2010) Protein kinase G type Iα activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation, Mol. Cancer Res., 8, 578–591.
Ma, L., and Wang, H. Y. (2007) Mitogen-activated protein kinase p38 regulates the Wnt/cyclic GMP/Ca2+ non-canonical pathway, J. Biol. Chem., 282, 28980–28990.
Konig, A., Fernandez-Zapico, M. E., and Ellenrieder, V. (2010) Primers on molecular pathways — the NFAT transcription pathway in pancreatic cancer, Pancreatology, 10, 416–422.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © M. O. Golovastova A. V. Bazhin, P. P. Philippov, 2014, published in Biokhimiya, 2014, Vol. 79, No. 8, pp. 923–931.
Rights and permissions
About this article
Cite this article
Golovastova, M.O., Bazhin, A.V. & Philippov, P.P. Cancer-retina antigens — A new group of tumor antigens. Biochemistry Moscow 79, 733–739 (2014). https://doi.org/10.1134/S000629791408001X
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S000629791408001X